Relevia UC-II Ingredients & Drug Interactions
What is this page for?
First and foremost: checking Relevia UC-II against your medications. The heart of this page is the interaction checker and the full interaction report — how this product’s ingredients may interact with prescription and over-the-counter medicines you may be taking.
Around that, we add a pharmacist’s high-level view of the product as a whole — what’s inside, the evidence for its stated use, how transparent the label is, and what safety data exists — so you can see the full picture in one place. It’s educational information from our licensed clinical databases and the clinical staff at HelloPharmacist — not medical advice — and we don’t sell or endorse products. Our editorial policy
Relevia UC-II is a dietary supplement by NewtonEverett with 5 active ingredients. Its ingredients are commonly taken for skin hydration and aging, joint comfort and osteoarthritis, dry eyes.Based on those ingredients, 62 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are Potassium Chloride. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.
Check Your Meds Against Relevia UC-II by NewtonEverett
Ask about any prescription or over-the-counter medication and we check it for interactions with Relevia UC-II by NewtonEverett — and tell you which ingredient is responsible.
AI summaries are generated from our interaction database for education only — always confirm with your pharmacist. How we use AI
Ask the Pharmacist
A licensed pharmacist will answer your question by email — free, usually within 24 hours.
Got it — thank you!
A licensed pharmacist will answer within 24 hours. Keep an eye on your email (worth checking spam, just in case).
HelloPharmacist Scorecard of Relevia UC-II by NewtonEverett
Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.
What’s inside
Partial disclosure
Relevia UC-II contains five active ingredients. Potassium chloride is a mineral supplement form of potassium.
Hyaluronic acid is a naturally occurring compound in joints and connective tissue. Boron glycinate is boron bound to the amino acid glycine.
The product also includes cartilage and a standardized cartilage blend (UC-II), which are forms of collagen thought to support joint structure, plus a total collagen component. The capsule itself and the rice flour, magnesium stearate, and silica are inactive ingredients that help hold the formula together.
Does it work?
Strong evidence
Hyaluronic acid is possibly effective for dry eye and venous leg ulcers (slow-healing leg wounds), but there isn't enough evidence to rate it for aging skin, hay fever, or sexual dysfunction. Boron glycinate is likely effective for boron deficiency and possibly effective for vaginal yeast infections and radiation-related skin damage, though it appears possibly ineffective for athletic performance.
The effectiveness data we hold doesn't cover potassium supplementation, cartilage, or collagen for any specific use, so we can't speak to what this product may do for joint health or any other purpose.
How safe is it?
Well-documented data
Potassium is generally well tolerated by mouth, but excess levels can cause serious problems—especially in people with kidney disease. Common side effects are abdominal pain, nausea, diarrhea, and bloating; in rare cases, high potassium can cause irregular heartbeat, heart block, low blood pressure, and confusion.
Boron is generally safe in small dietary amounts and low doses, but high doses can be toxic. Hyaluronic acid appears well tolerated overall, though long-term safety of oral supplements isn't fully studied.
For pregnancy and breastfeeding: potassium from food is fine, but the data advises against using potassium supplements during pregnancy and breastfeeding without medical guidance. Boron supplements are advised against in pregnancy and breastfeeding due to potential fetal harm and insufficient safety data.
We have no pregnancy/breastfeeding information on file for hyaluronic acid.
Meds to double-check
Moderate interaction found
Check with your pharmacist if you take potassium-sparing diuretics, ACE inhibitors, or angiotensin receptor blockers (ARBs)—these all carry a Moderate risk of dangerously high potassium levels when combined with this product. People with kidney disease are at extra risk.
No interactions are documented for the hyaluronic acid, boron, or cartilage components with any medications we could check.
The bottom line
Scorecard at a glancePartially disclosed formula with clinical evidence supporting its stated purpose. Moderate medication interactions have been identified, and safety information is well characterized.
This product is mainly a potassium and joint-support formula. If you take blood pressure medications—especially diuretics, ACE inhibitors, or ARBs—you need to check with your pharmacist before starting it, because potassium can interact dangerously with those drugs.
Anyone with kidney disease should also talk to their doctor first. If you're pregnant or breastfeeding, discuss this with your doctor before taking it.
Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI
Assessment coverage: 3 of 5 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated Jan 25, 2018.
This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed
General information
Key facts about Relevia UC-II, straight from the product label.
| Brand | NewtonEverett |
|---|---|
| Barcode (UPC) | 818423028880 |
| Net contents | 30 Capsule(s) |
| Market status | On market |
| Date entered into DSLD | Jan 25, 2018 |
| DSLD ID | 82648 |
| Product type | Other Combinations |
| Supplement form | Capsule |
| Dietary claims / uses | All Other, Structure/Function |
| Intended target group(s) | Adult (18 - 50 Years) |
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.
Supplement Facts
The label details for Relevia UC-II by NewtonEverett, sourced from the NIH Dietary Supplement Label Database.
Supplement Facts
| Ingredient | Amount | % DV |
|---|---|---|
| Potassium Chloride | 0 NP | -- |
| Hyaluronic Acid | 3.3 mg | -- |
| Boron Glycinate | 5 mg | -- |
| Cartilage | 0 NP | -- |
| UC-II standardized Cartilage Blend | 40 mg | -- |
| total Collagen | 10 mg | -- |
Other ingredients: HPMC Vegetable Capsule, Rice Flour, Vegetable Magnesium Stearate, Silicon Dioxide
Tap any ingredient to jump to its full detail below.
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
Formula
Superflex-UC-II with undenatured type II collagen provides convenient & effective joint, cartilage and bone health.
1) UC-II is derived from protein found in natural cartilage. It works to promote a healthy immune response for improved joint and cartilage health 2) Hyaluronic acid provides cushioning and lubrication for joint comfort 3) Boron improves absorption of calcium, magnesium and vitamin D for strong, healthy bones
UC-II Collagen 40mg Boron 5mg Hyaluronic Acid 3.3mg
Suggested/Recommended/Usage/Directions
Just one small capsule daily contains three advanced ingredients for increased comfort and mobility to support your active lifestyle.
Just 1 small capsule per day
Suggested Use: As a dietary supplement, take one (1) capsule daily.
Brand IP Statement(s)
UC-II is a registered trademark of InterHealth N.I. UC-II brand collagen with undenatured type II collagen (U.S. Patents 7,846,487, 7,083,820 and EP0 Patent EP1435906B1; Canadian patent CA 2459981C; and Japanese Patent JP 4800574B2).
FDA Disclaimer Statement
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
General Statements
Joint, cartilage & bone Advanced action
Flexibility Comfort Mobility
Actual size
FDA Statement of Identity
Dietary Supplement
Precautions
Warning: Consult a physician before using if pregnant, nursing or on medication.
Do not use if safety seal is broken. Do not exceed suggested daily intake.
Keep out of reach of children.
Storage
Store in a cool, dry place.
General
#12476 - K16
Is this label outdated? Report a formula or label change and our pharmacy team will review it.
Relevia UC-II by NewtonEverett label
The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.
Label images are published by the NIH Dietary Supplement Label Database for the version of this product on file. Always read your actual product label.
View the full label (PDF)The Ingredients in Relevia UC-II by NewtonEverett
These are the 5 active ingredients this product is made of. Select any to open its full monograph.
Serving size1 Capsule(s) Dosage formCapsule Servings per container30 Amounts shown are per serving.
Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.
Hyaluronic Acid
No knowninteractions
Hyaluronic acid is a natural substance in the body that helps hold water in the skin, joints, and eyes. Oral and topical products are popular for skin...
Hyaluronic Acid monograph & interactionsBoron Glycinate
No knowninteractions
Boron is a trace mineral found in many plant foods and sold as a supplement, mainly promoted for bone, joint, and hormone health. The human evidence f...
Boron Glycinate monograph & interactionsUC-II standardized Cartilage Blend
- › Potassium Chloride
- › Cartilage
- › Total Collagen
Other (inactive) ingredients: HPMC Vegetable Capsule, Rice Flour, Vegetable Magnesium Stearate, Silicon Dioxide. These complete the product’s ingredient list but are not active constituents.
Relevia UC-II by NewtonEverett Drug Interactions
HelloPharmacist Interaction Report
Relevia UC-II by NewtonEverett contains potassium chloride, which interacts with several common blood pressure and heart medications.
The most serious concern is potassium-sparing diuretics (water pills that keep potassium in your body)—combining them with this product raises your risk of dangerously high potassium levels (hyperkalemia), a Moderate-severity interaction that can cause irregular heartbeat and heart block.
Read the full breakdown — every affected drug type, severity by severity
ACE inhibitors and angiotensin receptor blockers (ARBs)—two major classes of blood pressure medication—also carry a Moderate risk of high potassium when paired with potassium supplements. These drugs already reduce how much potassium your kidneys excrete, so adding a potassium supplement on top can push levels into a dangerous zone.
Hyaluronic acid, boron glycinate, and the cartilage ingredients have no documented interactions with medications, though we could not check cartilage or the total collagen component because data isn't on file for them. Altogether, these interactions span 62 individual medications.
If you're on any blood pressure or diuretic medication, run your exact drugs through the interaction checker below before starting this product.
Check your own medications below · Editorial policy · How we use AI
Want to check YOUR meds against Relevia UC-II?
Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.
Go to the checkerIngredients driving the most interactions
Individual Drug Interactions
The ingredients in Relevia UC-II interact with 62 drugs. Click any drug to see the details.
1 of the 5 ingredients in Relevia UC-II interact with drugs. Each result below shows which ingredient is responsible. Potassium Chloride
AmilorideAmilamont, Midamor
How Amiloride interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChloridePotassium-sparing Diuretics Moderate
Interaction Summary
Concomitant use increases the risk of hyperkalemia.
Read the full Potassium Chloride + Amiloride interactionAmiloride, HydrochlorothiazideAmil-Co, Amilzide, Moduret 25, Moduretic
How Amiloride, Hydrochlorothiazide interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChloridePotassium-sparing Diuretics Moderate
Interaction Summary
Concomitant use increases the risk of hyperkalemia.
Read the full Potassium Chloride + Amiloride, Hydrochlorothiazide interactionAmlodipine Besylate, BenazeprilLotrel
How Amlodipine Besylate, Benazepril interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChlorideAce Inhibitors (aceis) Moderate
Interaction Summary
Using ACEIs with high doses of potassium increases the risk of hyperkalemia.
Read the full Potassium Chloride + Amlodipine Besylate, Benazepril interactionAzilsartanEdarbi
How Azilsartan interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChlorideAngiotensin Receptor Blockers (arbs) Moderate
Interaction Summary
Using ARBs with high doses of potassium increases the risk of hyperkalemia.
Read the full Potassium Chloride + Azilsartan interactionAzilsartan, ChlorthalidoneEdarbyclor
How Azilsartan, Chlorthalidone interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChlorideAngiotensin Receptor Blockers (arbs) Moderate
Interaction Summary
Using ARBs with high doses of potassium increases the risk of hyperkalemia.
Read the full Potassium Chloride + Azilsartan, Chlorthalidone interactionBenazeprilLotensin
How Benazepril interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChlorideAce Inhibitors (aceis) Moderate
Interaction Summary
Using ACEIs with high doses of potassium increases the risk of hyperkalemia.
Read the full Potassium Chloride + Benazepril interactionBenazepril, HydrochlorothiazideLotensin HCT
How Benazepril, Hydrochlorothiazide interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChlorideAce Inhibitors (aceis) Moderate
Interaction Summary
Using ACEIs with high doses of potassium increases the risk of hyperkalemia.
Read the full Potassium Chloride + Benazepril, Hydrochlorothiazide interactionBendroflumethiazide, PotassiumCentyl K, Neo-NaClex-K
How Bendroflumethiazide, Potassium interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChloridePotassium-sparing Diuretics Moderate
Interaction Summary
Concomitant use increases the risk of hyperkalemia.
Read the full Potassium Chloride + Bendroflumethiazide, Potassium interactionBumetanide, PotassiumBurinex K
How Bumetanide, Potassium interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChloridePotassium-sparing Diuretics Moderate
Interaction Summary
Concomitant use increases the risk of hyperkalemia.
Read the full Potassium Chloride + Bumetanide, Potassium interactionCandesartan CilexetilAmias, Atacand
How Candesartan Cilexetil interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChlorideAngiotensin Receptor Blockers (arbs) Moderate
Interaction Summary
Using ARBs with high doses of potassium increases the risk of hyperkalemia.
Read the full Potassium Chloride + Candesartan Cilexetil interactionCandesartan Cilexetil, HydrochlorothiazideAtacand HCT
How Candesartan Cilexetil, Hydrochlorothiazide interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChlorideAngiotensin Receptor Blockers (arbs) Moderate
Interaction Summary
Using ARBs with high doses of potassium increases the risk of hyperkalemia.
Read the full Potassium Chloride + Candesartan Cilexetil, Hydrochlorothiazide interactionCaptoprilAcepril, Capoten
How Captopril interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChlorideAce Inhibitors (aceis) Moderate
Interaction Summary
Using ACEIs with high doses of potassium increases the risk of hyperkalemia.
Read the full Potassium Chloride + Captopril interactionCaptopril, HydrochlorothiazideAcezide, Capozide
How Captopril, Hydrochlorothiazide interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChlorideAce Inhibitors (aceis) Moderate
Interaction Summary
Using ACEIs with high doses of potassium increases the risk of hyperkalemia.
Read the full Potassium Chloride + Captopril, Hydrochlorothiazide interactionCilazaprilInhibace
How Cilazapril interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChlorideAce Inhibitors (aceis) Moderate
Interaction Summary
Using ACEIs with high doses of potassium increases the risk of hyperkalemia.
Read the full Potassium Chloride + Cilazapril interactionDibasic Sodium Phosphate, Monobasic Potassium Phosphate, Monobasic Sodium Phosphate Monohydrate (prescription Drug)K-Phos Neutral
How Dibasic Sodium Phosphate, Monobasic Potassium Phosphate, Monobasic Sodium Phosphate Monohydrate (prescription Drug) interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChloridePotassium-sparing Diuretics Moderate
Interaction Summary
Concomitant use increases the risk of hyperkalemia.
Read the full Potassium Chloride + Dibasic Sodium Phosphate, Monobasic Potassium Phosphate, Monobasic Sodium Phosphate Monohydrate (prescription Drug) interactionDiltiazem, EnalaprilTeczem
How Diltiazem, Enalapril interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChlorideAce Inhibitors (aceis) Moderate
Interaction Summary
Using ACEIs with high doses of potassium increases the risk of hyperkalemia.
Read the full Potassium Chloride + Diltiazem, Enalapril interactionDrospirenoneDrospirenone
How Drospirenone interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChloridePotassium-sparing Diuretics Moderate
Interaction Summary
Concomitant use increases the risk of hyperkalemia.
Read the full Potassium Chloride + Drospirenone interactionDrospirenone, EstetrolNextstellis
How Drospirenone, Estetrol interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChloridePotassium-sparing Diuretics Moderate
Interaction Summary
Concomitant use increases the risk of hyperkalemia.
Read the full Potassium Chloride + Drospirenone, Estetrol interactionDrospirenone, Ethinyl EstradiolAngeliq, Gianvi, Yasmin
How Drospirenone, Ethinyl Estradiol interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChloridePotassium-sparing Diuretics Moderate
Interaction Summary
Concomitant use increases the risk of hyperkalemia.
Read the full Potassium Chloride + Drospirenone, Ethinyl Estradiol interactionEnalapril MaleateEpaned, Vasotec
How Enalapril Maleate interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChlorideAce Inhibitors (aceis) Moderate
Interaction Summary
Using ACEIs with high doses of potassium increases the risk of hyperkalemia.
Read the full Potassium Chloride + Enalapril Maleate interactionEnalapril Maleate, FelodipineLexxel
How Enalapril Maleate, Felodipine interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChlorideAce Inhibitors (aceis) Moderate
Interaction Summary
Using ACEIs with high doses of potassium increases the risk of hyperkalemia.
Read the full Potassium Chloride + Enalapril Maleate, Felodipine interactionEnalapril Maleate, HydrochlorothiazideVaseretic
How Enalapril Maleate, Hydrochlorothiazide interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChlorideAce Inhibitors (aceis) Moderate
Interaction Summary
Using ACEIs with high doses of potassium increases the risk of hyperkalemia.
Read the full Potassium Chloride + Enalapril Maleate, Hydrochlorothiazide interactionEprosartanTeveten
How Eprosartan interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChlorideAngiotensin Receptor Blockers (arbs) Moderate
Interaction Summary
Using ARBs with high doses of potassium increases the risk of hyperkalemia.
Read the full Potassium Chloride + Eprosartan interactionEthinyl Estradiol, DrospirenoneYaz
How Ethinyl Estradiol, Drospirenone interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChloridePotassium-sparing Diuretics Moderate
Interaction Summary
Concomitant use increases the risk of hyperkalemia.
Read the full Potassium Chloride + Ethinyl Estradiol, Drospirenone interactionFinerenoneKerendia
How Finerenone interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChloridePotassium-sparing Diuretics Moderate
Interaction Summary
Concomitant use increases the risk of hyperkalemia.
Read the full Potassium Chloride + Finerenone interactionFosinoprilMonopril
How Fosinopril interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChlorideAce Inhibitors (aceis) Moderate
Interaction Summary
Using ACEIs with high doses of potassium increases the risk of hyperkalemia.
Read the full Potassium Chloride + Fosinopril interactionFosinopril, HydrochlorothiazideMonopril HCT
How Fosinopril, Hydrochlorothiazide interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChlorideAce Inhibitors (aceis) Moderate
Interaction Summary
Using ACEIs with high doses of potassium increases the risk of hyperkalemia.
Read the full Potassium Chloride + Fosinopril, Hydrochlorothiazide interactionFurosemide, PotassiumDiumide-K Continus, Lasikal
How Furosemide, Potassium interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChloridePotassium-sparing Diuretics Moderate
Interaction Summary
Concomitant use increases the risk of hyperkalemia.
Read the full Potassium Chloride + Furosemide, Potassium interactionHydrochlorothiazide, IrbesartanAvalide
How Hydrochlorothiazide, Irbesartan interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChlorideAngiotensin Receptor Blockers (arbs) Moderate
Interaction Summary
Using ARBs with high doses of potassium increases the risk of hyperkalemia.
Read the full Potassium Chloride + Hydrochlorothiazide, Irbesartan interactionHydrochlorothiazide, LisinoprilPrinzide, Zestoretic
How Hydrochlorothiazide, Lisinopril interacts with Relevia UC-II — through 1 ingredient. Tap an ingredient for the detail:
Potassium ChlorideAce Inhibitors (aceis) Moderate
Interaction Summary
Using ACEIs with high doses of potassium increases the risk of hyperkalemia.
Read the full Potassium Chloride + Hydrochlorothiazide, Lisinopril interactionEach ingredient & the kinds of drugs it affects
For each ingredient in Relevia UC-II with known interactions, here are the types of medications it can affect. Open any type for the detail — or search your exact drug in the checker above.
Potassium Chloride
Ace Inhibitors (Aceis)
Using ACEIs with high doses of potassium increases the risk of hyperkalemia.
ACEIs block the actions of the renin-angiotensin-aldosterone system and reduce potassium excretion. Concomitant use of these drugs with potassium supplements increases the risk of hyperkalemia. However, concomitant use of these drugs with moderate dietary potassium intake (about 3775-5200 mg daily) does not increase serum potassium levels.
Angiotensin Receptor Blockers (Arbs)
Using ARBs with high doses of potassium increases the risk of hyperkalemia.
ARBs block the actions of the renin-angiotensin-aldosterone system and reduce potassium excretion. Concomitant use of these drugs with potassium supplements increases the risk of hyperkalemia. However, concomitant use of these drugs with moderate dietary potassium intake (about 3775-5200 mg daily) does not increase serum potassium levels.
Potassium-Sparing Diuretics
Concomitant use increases the risk of hyperkalemia.
Using potassium-sparing diuretics with potassium supplements increases the risk of hyperkalemia.
Brand information
Manufacturer and brand details for Relevia UC-II, from the product label.
NewtonEverett
See all NewtonEverett products- Name
- Newton-Everett Biotech
- City
- Scottsdale
- State
- AZ
- ZipCode
- 85255
- Phone Number
- 866.593.3424
- Web Address
- www.newton-everett.com
Relevia UC-II by NewtonEverett: Common Questions
Does Relevia UC-II by NewtonEverett interact with any medications?
How can one product interact with so many drugs?
Where does this information come from?
What is UC-II and why is it in this product?
Why does this product have potassium in it?
Can I take this if I'm pregnant or breastfeeding?
What are the most common side effects?
Is this safe for people with kidney disease?
Does this product have any fillers?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Not sure if Relevia UC-II is safe with your meds?
Our pharmacists answer your medication & supplement questions — free.
Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.
The Full Monographs Behind Relevia UC-II’s Ingredients
Every ingredient we hold a full HelloPharmacist monograph for — uses, evidence, safety, and the complete interaction list.
Hyaluronic Acid
Hyaluronic acid is a natural substance in the body that helps hold water in the skin, joints, and eyes. Oral and topical products are popular for skin moisture and joint comfort, and the evi...
Read the full Hyaluronic Acid monograph → Herb & supplement monographBoron
Boron is a trace mineral found in many plant foods and sold as a supplement, mainly promoted for bone, joint, and hormone health. The human evidence for most of these uses is limited or prel...
Read the full Boron monograph → Herb & supplement monographPotassium
Interacts with 62 drugsPotassium is an essential mineral your body needs for nerve signals, muscle function, and a steady heartbeat, and most people get enough from a balanced diet rich in fruits and vegetables. P...
Read the full Potassium monograph →Sources & How We Checked
Relevia UC-II's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.
- NIH Dietary Supplement Label Database (DSLD) — The official product label on file for this supplement.
- Natural Medicines (Therapeutic Research Center) — Evidence-graded clinical reference behind the ingredient interaction data.
Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.
The 22 references behind this product’s interaction data
Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.
Potassium 12 references
- McEvoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1998.
- Gennaro A. Remington: The Science and Practice of Pharmacy. 19th ed. Lippincott: Williams & Wilkins, 1996.
- Whelton PK, He J, Cutler JA, et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 1997;277:1624-32. PubMed
- Phillips, C. O., Kashani, A., Ko, D. K., Francis, G., and Krumholz, H. M. Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from ra DOI
- Altieri, P. I., Herrero, C., Suero, R., and Ortiz, A. Bleeding duodenal ulcer in a patient taking slow-releasing potassium tablets. Bol.Asoc.Med P.R. 1977;69(8):276.
- Raf, L. E. Enteric-coated potassium chloride tablets and ulcer of the small intestine. Acta Chir Scand Suppl 1967;(374):1-87.
- Potassium chloride oral solution [package insert]. Allentown, PA: Lehigh Valley Technologies, Inc.; 2014.
- Potassium chloride injection [package insert]. Lake Forest, IL: Hospira Inc.; 2009.
- Patel RB, Tannenbaum S, Viana-Tejedor A, et al. Serum potassium levels, cardiac arrhythmias, and mortality following non-ST-elevation myocardial infarction or unstable angina: insights from MERLIN-TIMI 36. Eur Heart J Acute Cardiovasc Care 2017 Feb;6(1):1 PubMed
- Malta D, Arcand J, Ravindran A, Floras V, Allard JP, Newton GE. Adequate intake of potassium does not cause hyperkalemia in hypertensive individuals taking medications that antagonize the renin angiotensin aldosterone system. Am J Clin Nutr 2016 Oct;104(4 PubMed
- Keskin M, Kaya A, Tatlisu MA, et al. The effect of serum potassium level on in-hospital and long-term mortality in ST elevation myocardial infarction. Int J cardiol. 2016 Oct 15;221:505-10.
- Stallings VA, Harrison M, Oria M; Committee to Review the Dietary Reference Intakes for Sodium and Potassium, Food and Nutrition Board, Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine. Washington (DC): National Acad
Hyaluronic Acid 4 references
- Park Y, Song JS, Choi CY, Yoon KC, Lee HK, Kim HS. A randomized multicenter study comparing 0.1%, 0.15%, and 0.3% sodium hyaluronate with 0.05% cyclosporine in the treatment of dry eye. J Ocul Pharmacol Ther. 2017;33(2):66-72. PubMed
- U.S. Food and Drug Administration. Do Not Use Needle-Free Devices for Injection of Dermal Fillers - FDA Safety Communication. October 8, 2021. Available at: https://www.fda.gov/medical-devices/safety-communications/do-not-use-needle-free-devices-injection
- Disphanurat W, Srisantithum B. Efficacy and safety of 0.15% isobutylamido thiazolyl resorcinol combined with hyaluronic acid vs 0.15% isobutylamido thiazolyl resorcinol or hyaluronic acid alone in melasma treatment: A randomized evaluator-blind trial. J C PubMed
- Humbert P, Mikosinki J, Benchikhi H, Allaert FA. Efficacy and safety of a gauze pad containing hyaluronic acid in treatment of leg ulcers of venous or mixed origin: a double-blind, randomised, controlled trial. Int Wound J 2013;10(2):159-66. PubMed
Boron 6 references
- Ellenhorn MJ, et al. Ellenhorn's Medical Toxicology: Diagnoses and Treatment of Human Poisoning. 2nd ed. Baltimore, MD: Williams & Wilkins, 1997.
- Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academy Press, 2002.
- Thai L, Hart LL. Boric acid vaginal suppositories. Ann Pharmacother 1993;27:1355-7.
- Acs N, Banhidy F, Puho E, Czeizel AE. Teratogenic effects of vaginal boric acid treatment during pregnancy. Int J Gynaecol Obstet 2006;93:55-6. PubMed
- Garabrant, D. H., Bernstein, L., Peters, J. M., and Smith, T. J. Respiratory and eye irritation from boron oxide and boric acid dusts. J Occup Med 1984;26(8):584-586. PubMed
- Hjelm C, Harari F, Vahter M. Pre- and postnatal environmental boron exposure and infant growth: results from a mother-child cohort in northern Argentina. Environ Res 2019;171:60-8. PubMed
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC